Gastrointestinal stromal tumors - Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

Virchows Archiv

Volumn 438, Issue 1, 2001, Pages 1-12

  Miettinen, Markku ^a   Lasota, Jerzy ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Gastrointestinal stromal tumors; GI autonomic nerve tumors; GI tract; Smooth muscle actin

Indexed keywords

ALPHA ACTIN; CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ANTIGEN EXPRESSION; CHROMOSOME 14Q; CHROMOSOME 22Q; CLINICAL EXAMINATION; COLON; COMPARATIVE GENOMIC HYBRIDIZATION; DIFFERENTIAL DIAGNOSIS; EPITHELIOID CELL; ESOPHAGUS; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MESENCHYME; NEURILEMOMA; PRIORITY JOURNAL; RECTUM; REVIEW; SMALL INTESTINE; SMOOTH MUSCLE FIBER; STOMACH; STROMA; TUMOR LOCALIZATION;

AMINO ACID SEQUENCE; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MOLECULAR SEQUENCE DATA; MUTATION; NEURILEMMOMA; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0035142836     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000338     Document Type: Review

References (81)

1. Leiomyosarcoma of the small and large bowel
2. Mesenchymal tumors of the gut: Histological perspectives, new approaches, new results, and does it make any difference
3. Paraffin section detection of the c-kit gene product (CD117) in human tissues: Value in the diagnosis of mast cell disorders
4. Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison on clinical subgroups
5. Inflammatory myofibro-blastic tumor, inflammatory fibrosarcoma, and related lesions: An historical review with differential diagnostic considerations
6. A flow cytometric, clinical and histological study of stromal neoplasms of the gastrointestinal tract
7. Predicting prognosis of gastrointestinal stromal smooth muscle tumors. Role of clinical and histologic evaluation, flow cytometry, and image cytometry
8. Benign schwannoma of the gastrointestinal tract: A clinicopathologic and immunohistochemical study
9. Does chromosome investigation discriminate between benign and malignant gastrointestinal leiomyomatous tumors
10. DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors
11. High resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract
12. Pronostic signficance of DNA copy number changes in benign and malignant GISTs
13. Ki-67 (MIB-1) immunohistochemistry as a prognostic factor in gastrointestinal smooth-muscle tumors
14. Prognosis of gastrointestinal smooth-muscle (stromal) tumors
15. Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry
16. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
17. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years
18. Muscle differentiation and clinicopathologic features of gastrointestinal stromal tumors
19. Differentiation and risk assessment of gastrointestinal stromal tumors
20. CD34 expression by inflammatory fibroid polyps of the gastrointestinal tract
21. Somatic deletion of the 5′ ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagus
22. Gastrointestinal autonomic nerve tumors "plexosaromas"
23. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
24. Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
25. Gastrointestinal pacemaker cell tumor a manifestation of neurofibromatosis I
26. Molecular pathology of c-kit proto-oncogene and development of gastrointestinal stromal tumors
27. Smooth muscle tumours of the gastrointestinal tract: Flow cytometric quantitation of DNA and nuclear antigen content and correlation with histological grade
28. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas and leiomyosarcomas
29. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of two hundred cases
30. Gastrointestinal autonomic nerve tumors. A clinicopathologic, immunohistochemical, and ultrastructural study of 12 cases
31. Origin of the c-kit positive interstitial cells in the avian bowel
32. Stromal tumours of the gastrointestinal tract: A clinicopathological and ploidy analysis of 33 cases
33. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
34. Requirement of c-kit for development of intestinal pacemaker system
35. Gastric stromal tumors. A reappraisal
36. Inflammatory flbrosarcoma: Update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors
37. Gastrointestinal stromal tumors - Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas
38. Gastrointestinal stromal tumors/smooth muscle tumors/GISTs in the omentum and mesentery - Clinicopathologic and immunohistochemical study of 26 cases
39. Heavy caldesmon and calponin in smooth muscle tumor and gastrointestinal stromal tumors
40. Gastrointestinal stromal tumors - New findings on their biology. A review
41. Esophageal stromal tumors - A clinicopathologic, immunohistochemical and molecular genetic study of seventeen cases and comparison with esophageal leiomyomas and leiomyosarcomas
42. Expression of KIT in angiosarcomas and fetal endothelial cells and lack of mutations in exons 11 and 17 of KIT
43. Colonic stromal tumors and leiomyosarcomas. A clinicopathologic, immunohistochemical and molecular genetic study of 44 cases
44. Immunohistochemical spectrum of GISTs of different locations and their differential diagnosis
45. CD34-expression in stromal tumors of the gastrointestinal tract
46. Small intestinal stromal tumors with skeinoid fibers. Clinicopathological, immunohistochemical, and ultrastructural investigations
47. CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses
48. Protooncogene c-kit expression in malignant melanoma: Protein loss with tumor progression
49. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors
50. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors
51. Familial gastrointestinal stromal tu mours with germline mutation of the KIT gene
52. Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointrestinal stromal/smooth muscle tumors
53. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum
54. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal
55. Immunophenotype, proliferation. DNA-ploidy, and biological behavior of gastrointestinal stromal tumors: A multivariate clinicopathologic study
56. Embryonic form of smooth muscle myosin heavy chain (SEmb/MCH-B) in gastrointestinal stromal tumor and interstitial cells of Cajal
57. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal
58. Leiomyosarcomas
59. A case for interstitial cells as pacemakers and mediators of neurotransmission in the gastrointestinal tract
60. Gastric schwannoma. Clinicopathologic analysis of six cases
61. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34
62. Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas and schwannomas
63. Solitary solid stromal gastrointestinal tumors in von Recklinghausen's disease with minimal smooth muscle differentiation
64. LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis
65. Leiomyomata of the esophagus. An analysis of 838 cases
66. Novel anti-cancer agents in development: Exciting prospects and new challenges
67. Myosarcomas of the stomach: Natural history, prognostic factors and management
68. Interstitial cells of Cajal as precursors for gastrointestinal stromal tumors
69. Gastrointestinal stromal tumors
70. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
71. Blockade of kit signalling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype
72. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma, and seminoma/dysgerminoma in humans: Immunohistochemical study of formalin-fixed, paraffin-embedded tissues
73. Stromal tumors of the jejunum and ileum
74. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome
75. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors
76. The CD34expression by gastrointestinal stromal tumors
77. An immunohistochemical study of inflammatory fibroid polyps of the gastrointestinal tract
78. Gastrointestinal autonomic nerve (GAN) tumor: Ultra-structural evidence for a newly recognized entity
79. Ultrastructure of gastric leiomyoma
80. Tyrosine kinase inhibitors
81. Origin of interstitial cells of Cajal in the mouse intestine